Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read moreSupporting UK agritech innovation
Ikarovec named as one of Scrip’s ‘10 To Watch’
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
AgPlus Diagnostics wins £230,000 in UK Government grants for COVID-19 diagnostic test development
Atelerix awarded Innovate UK funding to enable transport and storage of cellular therapies at room temperature
Tips for first-time fundraising
From academia to start-up: how to build a successful spin-out
Financial management in a crisis: how can early stage technology companies survive a pandemic
The Role of Public-Private Partnerships in the Future of Fusion Energy
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
New analysis confirms value of UKI2S investing public money to commercialise public science
How to build a start-up: Launching early stage science companies
Summary:
ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks such as syngas and methanol.
Its lead program…
read more